Considering these findings, CDNF emerges as a promising therapeutic candidate that could complement existing treatments in mitigating platelet-mediated thrombosis and inflammation processes, which, in turn, could reduce secondary brain injury and promote functional recovery in patients afflicted with ischemic stroke. This evidence concerns the gene CDNF and ischemic stroke.